Adrien Gagnon Féminex Veino
Adrien Gagnon Féminex Veino, NPN 80000341: natural health product licensed in Canada. Medicinal ingredients: Aesculus hippocastanum.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aesculus hippocastanum Extract : Solide Extraction ratio : 1:6 Dry plant equivalent : 1,667 mg Potency : 20 % | 250 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Gélatine, phosphate de dicalcium, Carbonate de magnésium, Eau purifiée, Stéarate de magnésium, chlorophylle, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours ; minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Utilise traditionnellement pour traiter lesinsuffisances veineuses.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consultez un fournisseur de soins de sante avant l'utilsation si vous prenez des anticoagulants. Consultez un fournisseur de soins de sante si vous souffrez de maladies de coagulation. Consultez un fournisseur de soins de sante si les symptomes persistent.
- Contre-indications
Ne pas utiliser en cas de grosseesse ou d'allaitement. Ne pas utilser si vous avez des desordres cardiaques, renaux et/ou du foie.
Product record
- Licence holder
- Santé Naturelle (A.G.) Ltée
- NPN or DIN-HM
- 80000341
- Status
- Inactive licence
- Licence date
- 23 March 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
Source
Official Health Canada record, licence 80000341
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Adrien Gagnon Féminex Veino (Santé Naturelle (A.G.) Ltée): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80000341-adrien-gagnon-feminex-veino, updated 23 March 2005.